, and NVIDIA has produced a notable advancement in the application of quantum computing to pharmaceutical research. According to the group, the effort resulted in a more than 20-fold increase in computational efficiency for simulating a key chemical reaction relevant to drug development.){kind=link}
A cross-industry collaboration involving IonQ, AstraZeneca, Amazon Web Services (AWS), and NVIDIA has produced a notable advancement in the application of quantum computing to pharmaceutical research. According to the group, the effort resulted in a more than 20-fold increase in computational efficiency for simulating a key chemical reaction relevant to drug development.
The joint research will be presented at the ISC High Performance conference in Hamburg this week. The project centered around a hybrid quantum-classical computing workflow, targeting the Suzuki-Miyaura reaction, an important class of chemical transformations used in synthesizing small molecule drugs.
The experiment used IonQ’s Forte quantum processing unit, integrated with NVIDIA’s CUDA-Q platform and deployed on AWS via Amazon Braket and AWS ParallelCluster. According to the researchers, this setup reduced the time required for a complex molecular simulation from months to days, while maintaining a high level of accuracy.
IonQ characterized the achievement as the most complex chemical simulation it has performed to date on its quantum hardware. While full-scale practical applications remain a long-term goal, the results suggest progress in overcoming key computational bottlenecks in early-stage drug discovery.
AstraZeneca’s Anders Broo, Executive Director of Pharmaceutical Science R&D, called the work a “step towards accurately modeling activation barriers” in catalyzed reactions.
AWS and NVIDIA echoed this sentiment, with both companies emphasizing the role of hybrid quantum-classical systems in future high-performance computing pipelines. AWS’s Eric Kessler noted that quantum computing is expected to complement, rather than replace, traditional computing infrastructure.
Though still in the research phase, the work highlights how distributed hybrid systems involving both quantum and classical hardware may help tackle problems that are currently intractable with conventional methods alone. The approach aligns with a broader trend of integrating quantum computing into existing scientific and industrial workflows in areas such as materials science and chemistry.